Human Phenotype Ontology 
Grandparent Node:
expand
Visual field defect (HP:0001123)help
Parent Node:
expand
Constriction of peripheral visual field (HP:0001133)help
..Starting node
..expand
Peripheral visual field loss (HP:0007994)help
Term ID: 7994
Name: Peripheral visual field loss
Synonym: Kalnienk vision; Loss of peripheral vision; Tunnel vision
Definition: Loss of peripheral vision with retention of central vision, resulting in a constricted circular tunnel-like field of vision.
Comments:
Reference: HP:0007994
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandMild constriction of peripheral visual field (HP:0030522) help
..expandModerate constriction of peripheral visual field (HP:0030525) help
..expandobsolete Peripheral visual field constriction with 30-39 degrees central field preserved (HP:0030524) help
..expandobsolete Peripheral visual field constriction with 40-50 degrees central field preserved (HP:0030523) help
..expandSevere constriction of peripheral visual field (HP:0030526) help
..expandVery severe constriction of peripheral visual field (HP:0030527) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0007994HP:0007994Peripheral visual field loss0ABCA4 CL E G H2434OMIM:604116CONE-ROD DYSTROPHY 3; CORD3826
HP:0007994HP:0007994Peripheral visual field loss0AGBL5 CL E G H6050926147OMIM:617023Retinitis pigmentosa 75.2
HP:0007994HP:0007994Peripheral visual field loss0ARL6 CL E G H8410013210OMIM:209900Bardet-Biedl syndrome 129
HP:0007994HP:0007994Peripheral visual field loss0BBS1 CL E G H582966OMIM:209900Bardet-Biedl syndrome 1114
HP:0007994HP:0007994Peripheral visual field loss0CCDC28B CL E G H7914028163OMIM:209900Bardet-Biedl syndrome 14
HP:0007994HP:0007994Peripheral visual field loss0CNGA1 CL E G H12592148OMIM:613756RETINITIS PIGMENTOSA 49; RP4944
HP:0007994HP:0007994Peripheral visual field loss0CNGB1 CL E G H12582151OMIM:613767Retinitis pigmentosa 45.164
HP:0007994HP:0007994Peripheral visual field loss0CRX CL E G H14062383OMIM:120970Cone-Rod dystrophy 2.158
HP:0007994HP:0007994Peripheral visual field loss0CWC27 CL E G H1028310664OMIM:250410Retinitis pigmentosa with or without skeletal anomalies4
HP:0007994HP:0007994Peripheral visual field loss0CYP1B1 CL E G H15452597ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent101
HP:0007994HP:0007994Peripheral visual field loss0DLAT CL E G H17372896ORPHA:79244Pyruvate dehydrogenase E2 deficiencyHP:0040283 - Occasional82
HP:0007994HP:0007994Peripheral visual field loss0EFEMP1 CL E G H22023218ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent54
HP:0007994HP:0007994Peripheral visual field loss0GUCY2D CL E G H30004689OMIM:601777Cone-Rod dystrophy 6.124
HP:0007994HP:0007994Peripheral visual field loss0IDS CL E G H34235389ORPHA:217093Mucopolysaccharidosis type 2, attenuated formHP:0040283 - Occasional86
HP:0007994HP:0007994Peripheral visual field loss0IDS CL E G H34235389ORPHA:217085Mucopolysaccharidosis type 2, severe formHP:0040283 - Occasional86
HP:0007994HP:0007994Peripheral visual field loss0IFT140 CL E G H974229077OMIM:266920Short-rib thoracic dysplasia 9 with or without polydactyly148
HP:0007994HP:0007994Peripheral visual field loss0LCA5 CL E G H16769131923ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent70
HP:0007994HP:0007994Peripheral visual field loss0LRAT CL E G H92276685ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent62
HP:0007994HP:0007994Peripheral visual field loss0MYOC CL E G H46537610ORPHA:98977Juvenile glaucomaHP:0040282 - Frequent47
HP:0007994HP:0007994Peripheral visual field loss0PDE6A CL E G H51458785OMIM:613810RETINITIS PIGMENTOSA 43; RP43116
HP:0007994HP:0007994Peripheral visual field loss0POU3F4 CL E G H54569217ORPHA:1435Xq21 microdeletion syndromeHP:0040282 - Frequent40
HP:0007994HP:0007994Peripheral visual field loss0PROM1 CL E G H88429454OMIM:612095RETINITIS PIGMENTOSA 41; RP41110
HP:0007994HP:0007994Peripheral visual field loss0PRPH2 CL E G H59619942ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent159
HP:0007994HP:0007994Peripheral visual field loss0RDH5 CL E G H59599940ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent32
HP:0007994HP:0007994Peripheral visual field loss0RHO CL E G H601010012ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent107
HP:0007994HP:0007994Peripheral visual field loss0RLBP1 CL E G H601710024ORPHA:52427Retinitis punctata albescensHP:0040282 - Frequent47
HP:0007994HP:0007994Peripheral visual field loss0RNU4ATAC CL E G H10015168334016OMIM:226960EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS15
HP:0007994HP:0007994Peripheral visual field loss0RPE65 CL E G H612110294OMIM:618697RETINITIS PIGMENTOSA 87 WITH CHOROIDAL INVOLVEMENT; RP87129
HP:0007994HP:0007994Peripheral visual field loss0RPE65 CL E G H612110294ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent129
HP:0007994HP:0007994Peripheral visual field loss0RRM2B CL E G H5048417296OMIM:268315ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL DYSFUNCTION125
HP:0007994HP:0007994Peripheral visual field loss0SDHA CL E G H638910680OMIM:619259NEURODEGENERATION WITH ATAXIA AND LATE-ONSET OPTIC ATROPHY; NDAXOA304
HP:0007994HP:0007994Peripheral visual field loss0SEMA4A CL E G H6421810729OMIM:610283Cone-Rod dystrophy 10.48
HP:0007994HP:0007994Peripheral visual field loss0SH3TC2 CL E G H7962829427ORPHA:99949Charcot-Marie-Tooth disease type 4CHP:0040284 - Very rare493
HP:0007994HP:0007994Peripheral visual field loss0SLC6A6 CL E G H653311052OMIM:145350Hypotaurinemic retinal degeneration and cardiomyopathy
HP:0007994HP:0007994Peripheral visual field loss0SPATA7 CL E G H5581220423ORPHA:364055Severe early-childhood-onset retinal dystrophyHP:0040282 - Frequent48
HP:0007994HP:0007994Peripheral visual field loss0ZNF513 CL E G H13055726498OMIM:613617Retinitis pigmentosa 58.27


Genes (34) :ABCA4 AGBL5 ARL6 BBS1 CCDC28B CNGA1 CNGB1 CRX CWC27 CYP1B1 DLAT EFEMP1 GUCY2D IDS IFT140 LCA5 LRAT MYOC PDE6A POU3F4 PROM1 PRPH2 RDH5 RHO RLBP1 RNU4ATAC RPE65 RRM2B SDHA SEMA4A SH3TC2 SLC6A6 SPATA7 ZNF513

Diseases (26) :OMIM:604116 OMIM:617023 OMIM:209900 OMIM:613756 OMIM:613767 OMIM:120970 OMIM:250410 ORPHA:98977 ORPHA:79244 OMIM:601777 ORPHA:217093 ORPHA:217085 OMIM:266920 ORPHA:364055 OMIM:613810 ORPHA:1435 OMIM:612095 ORPHA:52427 OMIM:226960 OMIM:618697 OMIM:268315 OMIM:619259 OMIM:610283 ORPHA:99949 OMIM:145350 OMIM:613617
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.